rock@uunet.UU.NET (02/25/90)
==============================
| WASHINGTON HIV NEWS |
==============================
Copyright (C) 1988, 1989, 1990 by Washington HIV News, all rights reserved.
Permission is granted for non-commercial use only.
---------------------------
January 1990 - Vol 1, No 4
DEPARTMENTS:
Opening -- Thanks for the help
Distribution
Staff
EDUCATION:
Portrait of AIDS in the 1990s: Lecture by Dr. Anthony Fauci
Medical Update: New treatment of HIV-infected individuals
The saga of ddI
TREATMENT:
Anti-retroviral protocols
AZT and Acyclovir
AZT & Acyclovir, ddI, and ddC combination study
ddC (2',3'-dideoxycytidine) vs. AZT (Retrovir or Zidovudine) in
patients with advanced ARC or AIDS
ddI vs. AZT for people with AIDS or Advanced ARC with no or short-
term prior AZT (ACTG 116)
ddI vs. AZT for people with AIDS or Advanced ARC with long-term
prior AZT (ACTG 117)
ddI for people with AIDS or Advanced ARC who are intolerant to AZT
(ACTG 118)
ddI (2',3'-dideoxyinosine) for people with HIV dementia
rCD4-IgG Conjugate ("Designer Gene") and AZT
rCD4-IgG Conjugate ("Designer Gene")
CMV Retinitis protocols
Foscarnet for sight-threatening CMV Retinitis (ACTG 093)
Pneumocystis carinii Pneumonia (PCP) protocols
Aerosolized Pentamidine vs. Dapsone vs.
Trimethoprim/Sulfamethoxazole (Bactrim) in combination with
AZT in ARC patients (ACTG 081)
Aerosolized Pentamidine vs. Trimethoprim/Sulfamethoxazole
(Bactrim) in combination with AZT in AIDS patients (ACTG 021)
Miscellaneous protocols
Coping Response in HIV infection
Foscarnet vs. Vidarabine to treat Acyclovir-resistant Herpes
Simplex (ACTG 095)
Neuropsychological testing
Previously covered protocols
Anti-retroviral protocols
CMV Retinitis protocols
Toxoplasmosis protocols
Miscellaneous protocols
---------------------------
The Washington HIV News is a newsletter containing information about
dealing with HIV infection in the Washington, D.C. area.
It has four main sections:
* Education, with articles about different aspects of understanding HIV
infection;
* Treatment, which has a listing of treatment protocols that are open to new
patients at the different research facilities in the Washington area (like the
National Cancer Institute, National Institutes on Allergy and Infectious
Diseases, George Washington University, Georgetown University, Veterans
Affairs Medical Center, Whitman-Walker Clinic, etc.);
* Services, which lists different things of practical interest to
HIV-infected people; and
* Departments, which contains the front page article, information on
distribution, and the staff list and policy statements.
The Washington HIV News is produced primarily for residents of the
Washington Metropolitan area. However, many of the protocols being run in
Washington are ACTG (AIDS Clinical Trial Group) studies, which are run at
many different centers across the country. Therefore, just because a study
is running at George Washington University in Washington doesn't mean it
might not also be running at San Francisco General Hospital. Call the
NIH/NIAID AIDS Trial Line at 1-(800) TRIALS-A [874-2572] to check.
Also, many of the NIH intramural protocols will pay to fly you in for
treatment, ONCE YOU ARE ACCEPTED INTO THE STUDY.
What this means is that IF the study permits non-residents and IF you
qualify for it, you will have to pay to come to Washington for the screening
interview, but if you are accepted, all of your travel and hotel bills after
that will be paid for by NIH. If in doubt, first read the requirements
section to make sure you qualify, and then call the person listed as the
contact at NIH.
... Andrew Coile.